Literature DB >> 23797203

Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX?

Andrew S Bomback1, Gerald B Appel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23797203     DOI： 10.1038/nrneph.2013.126

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.

Authors:  Michael Walsh; Fausta Catapano; Wladimir Szpirt; Kristian Thorlund; Annette Bruchfeld; Loic Guillevin; Marion Haubitz; Peter A Merkel; Chen Au Peh; Charles Pusey; David Jayne
Journal:  Am J Kidney Dis       Date:  2010-12-30       Impact factor: 8.860

2.  Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis.

Authors:  Sofia Lionaki; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2007-07       Impact factor: 10.121

3.  Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease.

Authors:  JulieAnne G McGregor; Susan L Hogan; Yichun Hu; Caroline E Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 8.237

4.  Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis.

Authors:  Ruth J Pepper; Dimitrios Chanouzas; Ruth Tarzi; Mark A Little; Alina Casian; Alina Caisian; Michael Walsh; Charles D Pusey; Lorraine Harper; Alan D Salama
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 8.237

Review 5.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

6.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Authors:  Michael Walsh; Alina Casian; Oliver Flossmann; Kerstin Westman; Peter Höglund; Charles Pusey; David R W Jayne
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

7.  A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group.

Authors:  E Cole; D Cattran; A Magil; C Greenwood; D Churchill; D Sutton; W Clark; P Morrin; G Posen; K Bernstein
Journal:  Am J Kidney Dis       Date:  1992-09       Impact factor: 8.860

Review 8.  Treatment of ANCA-associated vasculitides (AAV).

Authors:  Julia U Holle; Wolfgang L Gross
Journal:  Autoimmun Rev       Date:  2012-08-16       Impact factor: 9.754

9.  Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

Authors:  David R W Jayne; Gill Gaskin; Niels Rasmussen; Daniel Abramowicz; Franco Ferrario; Loic Guillevin; Eduardo Mirapeix; Caroline O S Savage; Renato A Sinico; Coen A Stegeman; Kerstin W Westman; Fokko J van der Woude; Robert A F de Lind van Wijngaarden; Charles D Pusey
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

10.  Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.

Authors:  Michael Walsh; Peter A Merkel; Chen Au Peh; Wladimir Szpirt; Loïc Guillevin; Charles D Pusey; Janak De Zoysa; Natalie Ives; William F Clark; Karen Quillen; Jeffrey L Winters; Keith Wheatley; David Jayne
Journal:  Trials       Date:  2013-03-14       Impact factor: 2.279
  10 in total
  2 in total

1.  Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.

Authors:  Rebecca L Manno; Philip Seo; Duvuru Geetha
Journal:  BMC Nephrol       Date:  2015-06-25       Impact factor: 2.388

2.  MRSA induced pulmonary-renal syndrome.

Authors:  Mohammed Megri; Majdi Al-Dliw; Yousef Shweihat; Zeid Khitan
Journal:  Respir Med Case Rep       Date:  2016-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.